Skip Navigation


JAC Advance Access originally published online on February 28, 2007
Journal of Antimicrobial Chemotherapy 2007 59(5):971-976; doi:10.1093/jac/dkm032
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
59/5/971    most recent
dkm032v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Blix, H. S.
Right arrow Articles by Rønning, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Blix, H. S.
Right arrow Articles by Rønning, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Age- and gender-specific antibacterial prescribing in Norway

Hege Salvesen Blix1,2,*, Anders Engeland1,3, Irene Litleskare1 and Marit Rønning1

1 Department of Pharmacoepidemiology, Norwegian Institute of Public Health, Marcus Thranes gate 6, NO-0403 Oslo, Norway 2 Department of Pharmacotherapeutics, Faculty of Medicine, University of Oslo, PO Box 1065 Blindern, NO-0316 Oslo, Norway 3 Department of Public Health and Primary Health Care, University of Bergen, Bergen, Norway

Received 7 November 2006; returned 11 December 2006; revised 19 January 2007; accepted 23 January 2007


* Corresponding author. E-mail: hegesbl{at}ulrik.uio.no

Objectives: To describe the use of antibacterials among outpatients in Norway and to explore patterns of age- and gender-specific use.

Methods: Data were extracted from the Norwegian Prescription Database (NorPD), a complete register of all dispensed prescriptions in Norway, in the period 1 July 2005–30 June 2006. NorPD contains data at an individual level. We extracted patients who had received an antibacterial for systemic use. Results were shown as population prevalences for the total population.

Results: A total of 1.1 million persons had at least one prescription for an antibacterial dispensed. The mean population prevalence of antibacterial use was 24% in total (28% and 19% for women and men, respectively). Population prevalence changed markedly between different age groups and between genders. Children (<5 years) and older elderly people (≥75 years) were high consumers. Females, in general, used more than males. Use by the different subgroups of antibacterials differed between gender and between different age groups. ß-Lactamase-sensitive penicillins was the most prevalent antibacterial group in all age groups except for women ≥75 years, for whom penicillins with extended spectrum were the most frequently used.

Individuals defined as high users (using more than 60 DDDs/year) represented 3% of the population who were using antibacterials. These patients were older and used co-medication more often than other users of antibacterials.

Conclusions: Over 1 year, a quarter of the total population used antibacterials. Patterns of use and types of drugs used differed markedly between genders and between different age groups.

Keywords: antibiotic use , population prevalence , DDD , prescriptions , antibacterials


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.